- Home
- ITRM vs NUWE Comparison
ITRM vs NUWE Comparison
Compare ITRM & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRM
- NUWE
- Stock Information
- Founded
- ITRM 2015
- NUWE 1999
- Country
- ITRM Ireland
- NUWE United States
- Employees
- ITRM N/A
- NUWE 38
- Industry
- ITRM Biotechnology: Pharmaceutical Preparations
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ITRM Health Care
- NUWE Health Care
- Exchange
- ITRM Nasdaq
- NUWE Nasdaq
- Market Cap
- ITRM 37.7M
- NUWE 3.9M
- IPO Year
- ITRM 2018
- NUWE N/A
- Fundamental
- Price
- ITRM $1.08
- NUWE $0.93
- Analyst Decision
- ITRM Strong Buy
- NUWE Strong Buy
- Analyst Count
- ITRM 1
- NUWE 1
- Target Price
- ITRM $5.00
- NUWE $17.00
- AVG Volume (30 Days)
- ITRM 300.3K
- NUWE 74.6K
- Earning Date
- ITRM 05-12-2025
- NUWE 05-06-2025
- Dividend Yield
- ITRM N/A
- NUWE N/A
- EPS Growth
- ITRM N/A
- NUWE N/A
- EPS
- ITRM N/A
- NUWE N/A
- Revenue
- ITRM N/A
- NUWE $8,740,000.00
- Revenue This Year
- ITRM N/A
- NUWE $22.96
- Revenue Next Year
- ITRM $150.10
- NUWE $29.97
- P/E Ratio
- ITRM N/A
- NUWE N/A
- Revenue Growth
- ITRM N/A
- NUWE N/A
- 52 Week Low
- ITRM $0.81
- NUWE $0.75
- 52 Week High
- ITRM $3.02
- NUWE $14.00
- Technical
- Relative Strength Index (RSI)
- ITRM 32.84
- NUWE 44.77
- Support Level
- ITRM $1.05
- NUWE $0.87
- Resistance Level
- ITRM $1.16
- NUWE $0.95
- Average True Range (ATR)
- ITRM 0.08
- NUWE 0.08
- MACD
- ITRM -0.00
- NUWE 0.01
- Stochastic Oscillator
- ITRM 13.04
- NUWE 64.29
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.